3rd Quarter - Report
AVENUE SOLUTIONS for GENENTECH USA, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; Issues related to insulin out of pocket costs; S. 954, Affordable Insulin Now Act of 2023; S. 1269, INSULIN Act of 2023; Issues related to healthcare access, quality and costs; Issues related to COVID rescissions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
Health Issues HCR
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.